Aridis Pharmaceuticals, Inc.

Quarterly Report for period ending 2023-09-30

Quarterly Report for period ending 2023-06-30

Quarterly Report for period ending 2023-03-31

Annual Report for period ending 2022-12-31

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2023-03-31

Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending 2022-12-31

Quarterly Report for period ending 2022-09-30

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2022-09-30

Quarterly Report for period ending 2022-06-30

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2022-06-30

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Annual report to security holders

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Exempt (Private) Offering

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

ARMISTICE CAPITAL, LLC: Major Shareholders

Lind Global Fund II LP: Major Shareholders

Truong Vu: Statement of changes in beneficial ownership of securities

Jafri Hasan: Statement of changes in beneficial ownership of securities

Windham-Bannister Susan Richards: Statement of changes in beneficial ownership of securities

HAMILTON JOHN F: Statement of changes in beneficial ownership of securities

Patzer Eric: Statement of changes in beneficial ownership of securities

Jafri Hasan: Statement of changes in beneficial ownership of securities

Windham-Bannister Susan Richards: Statement of changes in beneficial ownership of securities

HAMILTON JOHN F: Statement of changes in beneficial ownership of securities

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Definitive proxy statements

Definitive proxy statements